2ASTX727 Decitabine and Cedazuridine

Delivery:
oral
MOA:

Oral DNA methyltransferase inhibitor

Indication:

Acute Myeloid Leukemia in combination with venetoclax

Phase 1/2 Study in combination With venetoclax in AML